Professor Alasdair Coles

Alasdair Coles is the Professor of Neuroimmunology at the University of Cambridge. He was awarded the Medical Research Council Training Fellowship from 1994 to 1998, and the Wellcome Advanced Clinical Fellowship from 2000 to 2004. He was awarded his PhD in 1998 and has been a university lecturer in clinical neuroimmunology and a consultant neurologist since 2004. He is a medical advisor to the MS Society and was awarded fellowship of the Royal College of Physicians of London in 2008. Alasdair was closely involved in the development of alemtuzumab as a treatment of MS. Since then, he has set up trials of a novel remyelinating drug in MS and of immunotherapy in autoimmune psychosis. He is Chair of the MS Advisory Group of the Association of British Neurologists, and chaired the group that drew up the latest NHS England MS Treatment Algorithm.